Source: Eur Respir J , 49 (4)  1700374; DOI: 10.1183/13993003.00374-2017



Rating:

Share or cite this content

Citations should be made in the following way:
D. Rebecca Prevots, Robert Loddenkemper, Giovanni Sotgiu, Giovanni Battista Migliori. Nontuberculous mycobacterial pulmonary disease: an increasing burden with substantial costs. Eur Respir J , 49 (4)  1700374; DOI: 10.1183/13993003.00374-2017

Member's Comments

No comment yet.

Related content which might interest you: Beyond pulmonary nontuberculous mycobacteria disease: do extra-pulmonary forms represent an emerging clinical and public health threat? Source: ERJ Open Res, 3 (3) 00091-2017; 10.1183/23120541.00091-2017 Year: 2017 When is an infectious disease? The clinical spectrum of nontuberculous mycobacterial pulmonary disease Source: International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease Year: 2019 Nontuberculous pulmonary mycobacteriosis caused by slowly growing nontuberculous mycobacteria as pulmonary comorbidity Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease Year: 2021 Non-tuberculous mycobacterial pulmonary disease Source: Eur Respir J, 54 (1) 1900250; 10.1183/13993003.00250-2019 Year: 2019 Nontuberculous mycobacterial disease: an important cause of morbi-mortality in HIV infected subjects Source: Eur Respir J 2003; 22: Suppl. 45, 333s Year: 2003 The impact of new ATS/IDSA guideline for nontuberculous mycobacterial disease on the diagnosis of nontuberculous mycobacterial lung disease in Korea Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Management of pulmonary nontuberculous mycobacteria disease Source: Eur Respir Monogr 2018; 81: 222-237 Year: 2018 Nontuberculous mycobacterial infection in chronic obstructive pulmonary disease Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 The prevalence and clinical profile of non-tuberculous mycobacterial pulmonary infection in Singapore Source: International Congress 2018 – Respiratory epidemiology:  from infectious diseases to lung cancer Year: 2018 Cure rates in nontuberculous mycobacterial pulmonary disease Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 Prevalence of non-tuberculous mycobacterial disease among patients evaluated for pulmonary tuberculosis in Iraq 2015-2018 Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019 Nontuberculous mycobacterial disease in CF Source: ERS course 2015 Year: 2015 Burden of non-tuberculous mycobacterial pulmonary disease in Germany Source: Eur Respir J , 49 (4)  1602109; DOI: 10.1183/13993003.02109-2016 Year: 2017 Non-tuberculous mycobacterial lung disease and COPD Source: Eur Respir Monogr 2015; 69: 172-184 Year: 2015 Is low body fat responsible for increased susceptibility to nontuberculous mycobacterial lung disease? Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013 The cost of medical management of pulmonary nontuberculous mycobacterial disease in Ontario, Canada Source: Eur Respir J 2011; 37: 1158-1165 Year: 2011 Treatment of pulmonary NTM infection: can it be done? Source: Annual Congress 2007 - Nontuberculous mycobacteria (NTM): a slow-growing challenge Year: 2007 Non tuberculous mycobacterial pulmonary disease in the elderly Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis Year: 2020